Concepedia

Gerd J. Mander

GJ

Statistics

Publications

11

Citations

545

H-Index

11

Active since

2002

Affiliations

Max Planck Institute for Terrestrial Microbiology(Current)

MerLion Pharma (Germany)

European Molecular Biology Laboratory

Max Planck Institute of Biophysics

University of Regensburg

Gerd J. Mander is an author at Max Planck Institute for Terrestrial Microbiology specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

2002–2011

11

Publications

11

Physiological role of the F 420 -non-reducing hydrogenase (Mvh) from Methanothermobacter marburgensis

Alexander Stojanowic, Gerd J. Mander, Evert C. Duin et al. · Archives of Microbiology · 2003 · 94 citations

, , +10

Measuring the potency labelling of onabotulinumtoxinA (Botox®) and incobotulinumtoxinA (Xeomin®) in an LD50 assay

Dirk Dressler, Gerd J. Mander, Klaus Fink · Journal of Neural Transmission · 2011 · 77 citations

, , +4

Purification and characterization of a membrane‐bound enzyme complex from the sulfate‐reducing archaeon <i>Archaeoglobus fulgidus</i> related to heterodisulfide reductase from methanogenic archaea

Gerd J. Mander, Evert C. Duin, Dietmar Linder et al. · European Journal of Biochemistry · 2002 · 68 citations · Full text

Two distinct heterodisulfide reductase‐like enzymes in the sulfate‐reducing archaeon <i>Archaeoglobus profundus</i>

Gerd J. Mander, Antonio J. Pierik, Harald Huber et al. · European Journal of Biochemistry · 2004 · 66 citations · Full text

A Cysteine-Rich CCG Domain Contains a Novel [4Fe-4S] Cluster Binding Motif As Deduced from Studies with Subunit B of Heterodisulfide Reductase from <i>Methanothermobacter marburgensis</i>

Nils Hamann, Gerd J. Mander, Jacob E. Shokes et al. · Biochemistry · 2007 · 66 citations

1–5 of 11